HCA Healthcare, Inc. (NYSE:HCA) Stake Trimmed by Shayne & Jacobs LLC

Shayne & Jacobs LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 95,611 shares of the company’s stock after selling 430 shares during the quarter. HCA Healthcare comprises 7.5% of Shayne & Jacobs LLC’s investment portfolio, making the stock its 2nd biggest position. Shayne & Jacobs LLC’s holdings in HCA Healthcare were worth $28,698,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. MML Investors Services LLC grew its holdings in shares of HCA Healthcare by 31.7% in the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after purchasing an additional 4,285 shares during the period. Meritage Group LP acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $150,548,000. Galvin Gaustad & Stein LLC purchased a new position in HCA Healthcare in the fourth quarter worth approximately $18,044,000. Alpha DNA Investment Management LLC purchased a new stake in HCA Healthcare in the third quarter valued at $869,000. Finally, NRI Wealth Management LC purchased a new position in shares of HCA Healthcare during the 4th quarter worth $2,896,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE HCA opened at $333.30 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The business’s 50-day moving average price is $314.24 and its 200 day moving average price is $350.33. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market cap of $82.77 billion, a P/E ratio of 15.17, a P/E/G ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the firm earned $5.90 earnings per share. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

Analysts Set New Price Targets

Several brokerages have recently commented on HCA. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. KeyCorp dropped their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Barclays decreased their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Finally, Royal Bank of Canada decreased their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

Insiders Place Their Bets

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.